CBLL NASDAQ
CeriBell, Inc.
1W: -1.7%
1M: +11.1%
3M: +53.5%
YTD: +27.8%
1Y: +111.2%
$27.22
+0.19 (+0.70%)
After Hours: $29.48 (+2.27, +8.32%)
Weekly Expected Move ±8.9%
$22
$25
$27
$30
$32
Credit Risk of going bust: lower than 76% of companies Debt: 2.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.06 (down 99.8%), CeriBell, Inc. would be worth roughly what it owes.
Total debt $21.9M against a stock market value of $1.04B.
Distance to default 8.67 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $11.2M (short-term plus half of long-term), stock volatility 51.9%; Altman Z 14.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.06 (down 99.8%), CeriBell, Inc. would be worth roughly what it owes.
Total debt $21.9M against a stock market value of $1.04B.
Distance to default 8.67 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $11.2M (short-term plus half of long-term), stock volatility 51.9%; Altman Z 14.54. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.0B
52W Range10.85-28.11
Volume1,158,847
Avg Volume407,560
Beta0.81
Dividend—
Analyst Ratings
Company Info
CEOXingjuan Chao
Employees327
SectorHealthcare
IndustryMedical - Devices
IPO Date2024-10-11
Websiteceribell.com
360 North Pastoria Avenue
Sunnyvale, CA 94085
US
Sunnyvale, CA 94085
US
800 436 0826
About CeriBell, Inc.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
Latest News
Bank of America Corp DE Purchases New Shares in CeriBell, Inc. $CBLL
BlackRock Inc. Acquires New Holdings in CeriBell, Inc. $CBLL
Bank of America Corp DE Has $5.86 Million Position in CeriBell, Inc. $CBLL
Ceribell expects $114M-$117M 2026 revenue as CMS finalizes delirium NTAP up to $2,171 per patient
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Woo Raymond | S-Sale | 4,887 | $24.38 | 2026-10-01 |
| Chao Xingjuan | S-Sale | 20,846 | $25.03 | 2026-09-15 |
| Blumberg Scott | M-Exempt | 846 | $9.41 | 2026-09-15 |
| Blumberg Scott | S-Sale | 846 | $25.00 | 2026-09-15 |
| Blumberg Scott | M-Exempt | 846 | $9.41 | 2026-09-15 |